Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dendreon (DNDN) Expected to Report More Narrow Loss
Forbes
Friday, November 8, 2013 - 10:29am
tags:
earnings, Dendreon
Sequenom stock recovers following 3Q report
Yahoo/AP
Friday, November 8, 2013 - 10:06am
tags:
Sequenom, earnings
Peregrine presents data on bavituximab combined with anti-CTLA-4 antibodies
The Fly on the Wall
Friday, November 8, 2013 - 10:05am
tags:
bavituximab, Peregrine Pharmaceuticals, CTLA-4 monoclonal antibody
Axe Falls on Ariad’s Workforce After Cancer Drug Blowup
Xconomy
Friday, November 8, 2013 - 9:42am
tags:
Ariad Pharmaceuticals, layoffs, Iclusig
Sanofi To Manufacture Orexigen’s Contrave
Contract Pharma
Friday, November 8, 2013 - 9:36am
tags:
Sanofi, drug manufacturing, Contrave, Orexigen
Bristol-Myers Ends Some Discovery Work And Cuts R&D Jobs
Pharmalot
Friday, November 8, 2013 - 9:13am
tags:
R&D, Bristol-Myers Squibb, layoffs
Immunomedics announces IMMU-132 is active in patients refractory to Irinotecan
Yahoo/
Friday, November 8, 2013 - 9:13am
tags:
IMMU-132, Immunomedics, solid tumors
Neuroscience? It's Too Risky To Discover Drugs For That
Forbes
Friday, November 8, 2013 - 9:11am
tags:
Bristol-Myers Squibb, R&D, Neuroscience
AbbVie's Not as Vulnerable as the Street Believes
TheStreet.com
Friday, November 8, 2013 - 9:07am
tags:
AbbVie
Amarin's Q3 Call Points To Dark Days Ahead
Seeking Alpha
Friday, November 8, 2013 - 8:39am
tags:
Amarin, earnings
Arena Expands Deal With Eisai on Sales of Obesity Drug
Bloomberg
Friday, November 8, 2013 - 8:36am
tags:
Arena Pharmaceuticals, obesity, Eisai, Belviq
Salix bolsters gastro drug line-up with $2.6 billion Santarus buy
Yahoo/Reuters
Friday, November 8, 2013 - 8:23am
tags:
Salix, Santarus, M&A
EU agency questions AstraZeneca over heart drug trial
Reuters
Thursday, November 7, 2013 - 4:46pm
tags:
Europe, AstraZeneca, Brilinta
Which Big Pharma Is Poised to See Long-Term Gains?
Motley Fool
Thursday, November 7, 2013 - 11:00am
tags:
Bristol-Myers Squibb
Post-DoJ settlement, GlaxoSmithKline toes the line in Breo launch
Fierce Pharma
Thursday, November 7, 2013 - 10:11am
tags:
drug launches, GSK, Advair, Breo Ellipta
Scientists Try To Drag Drug Trials Into The DNA Age
Forbes
Thursday, November 7, 2013 - 10:04am
tags:
clinical trials
Hospira beats the Street with 3rd-quarter earnings
Mass Device
Thursday, November 7, 2013 - 9:57am
tags:
earnings, Hospira, devices
FTC OKs Rule Change For Patent Deals Over Pharma Objections
Pharmalot
Thursday, November 7, 2013 - 9:55am
tags:
patents, FTC
Agenus genital herpes vaccine succeeds in mid-stage trial
Reuters
Thursday, November 7, 2013 - 9:53am
tags:
vaccines, Agenus, genital herpes, HerpV
Gilead Vs. Challengers In The Hepatitis C Race
Seeking Alpha
Thursday, November 7, 2013 - 9:52am
tags:
Gilead, hepatitis C, AbbVie, Bristol-Myers Squibb, JNJ, Merck, simeprevir, sofosbuvir, daclatasvir

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.